Doceree Rolls Out Daily Command AI-Powered Commercialization Platform
The techmaker has been laying the groundwork for the launch for months.
After unveiling its artificial intelligence-powered operating system for health and pharma marketing this past spring, Doceree officially launched the Daily Command platform Tuesday.
The platform was designed and tested by a group of 75 senior leaders representing major pharmas and agencies, then beta tested by a smaller group of partners including Deerfield and Avalere Health. It’s now available to U.S. drugmakers, agencies and publishers.
Daily Command is meant to serve as a unified ecosystem for planning, executing and measuring marketing work, built around an interconnected intelligence layer dubbed Semmelweis and constructed as a pharma-specific reasoning and orchestration model.
Since pulling back the curtain on the platform in May, Doceree has announced a series of updates tied to its impending release.
In early June, the company unveiled Clinical Intent Signals, a key piece of intelligence software at the core of the new platform that aims to help marketers monitor and act on HCP behaviors in real time. Shortly after came the release of Trigger DOOH, a tool for boosting digital out-of-home targeting in clinical settings. And just last week, Doceree announced a closed-loop measurement framework that’s baked into Daily Command and seeks to standardize campaign measurement across channels commonly used to reach HCPs.
In the meantime, the techmaker also tapped new AI and innovation leaders. Both hires were tied to Daily Command’s debut, as Doceree said at the time that Yeshwanth “Yesh” Srinivasan and Graham Wilkinson, as chief AI officer and chief innovation officer, respectively, “will own the two capabilities that determine whether a category-defining platform endures.”
